Industry Research Reports
Home > Reports > Pharma & Healthcare > Global and China Human Coagulation Factor VII Market Report & Forecast 2024-2030
Global and China Human Coagulation Factor VII Market Report & Forecast 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-10-17
Pages: 86 Pages
Report ld: 3346932
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Coagulation Factor VII Market Size(US$)
CAGR 2024-2030
3.7%
Market Size,2030
USD 1,556
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 1,251 million
Market Forecast in 2030(Value)
US$ 1,556 million
CAGR
3.7%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
In its recombinant form, Recombinant Human Coagulation Factor VIIa (rFVIIa) is used as a medication to help control bleeding, particularly in patients with hemophilia or other bleeding disorders who have developed inhibitors to conventional therapies.
The global Human Coagulation Factor VII revenue was US$ 1206 million in 2023 and is forecast to a readjusted size of US$ 1556 million by 2030 with a CAGR of 3.7% during the review period (2024-2030).
In China the Human Coagulation Factor VII revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and China Human Coagulation Factor VII market, also covers the segmentation data of other regions in regional level and county level.
Drivers of the Recombinant Human Coagulation Factor VII Market:
Rising Prevalence of Hemophilia and Bleeding Disorders: Recombinant Factor VIIa is primarily used in treating hemophilia, especially in patients with inhibitors to Factor VIII or IX. The growing global incidence of hemophilia and other bleeding disorders is a major driver of market demand.
Advancements in Recombinant Technology: Ongoing improvements in biotechnology have led to the development of safer and more effective recombinant coagulation products. These advancements reduce the risk of bloodborne pathogen transmission, increasing their adoption over plasma-derived alternatives.
Increased Use in Trauma and Surgery: Recombinant Factor VIIa is also used in managing severe bleeding during trauma and surgical procedures, further expanding its clinical applications and boosting demand, particularly in emergency care settings.
Rising Adoption in Off-Label Uses: While its primary indication is for hemophilia, rFVIIa is increasingly being used off-label to manage uncontrolled bleeding in non-hemophiliac patients, particularly in critical care and trauma settings. This broadens its potential market.
Favorable Reimbursement Policies in Developed Regions: In regions like North America and Europe, the availability of comprehensive insurance and reimbursement for advanced therapies like rFVIIa makes these treatments more accessible to patients, supporting market growth.
Challenges of the Recombinant Human Coagulation Factor VII Market:
High Cost of Treatment: Recombinant Factor VIIa therapy is expensive, which can limit access, especially in low-income countries and regions without robust healthcare funding or insurance coverage.
Potential for Off-Label Use Concerns: Despite its increasing use in off-label applications, concerns about the safety and efficacy of rFVIIa in non-hemophilia patients have led to caution in its broader application. Regulatory scrutiny on off-label use may impact market expansion.
Limited Awareness and Access in Developing Regions: In many developing countries, awareness of recombinant therapies for hemophilia is limited, and access to advanced treatments is constrained by inadequate healthcare infrastructure and funding.
Competition from Alternative Therapies: Emerging gene therapies, extended half-life clotting factors, and other innovative treatments for hemophilia may compete with or reduce the demand for rFVIIa in the future. These newer therapies promise more long-term efficacy or convenience.
Regulatory Challenges: The stringent regulatory approval process for biologics, along with the ongoing need for post-market surveillance, can slow down the introduction of new products or indications, impacting the pace of market growth.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%.
Human Coagulation Factor VII market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Human Coagulation Factor VII market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For China market, this report focuses on the Human Coagulation Factor VII market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in China.
MARKET SEGMENTATION
By Company
- NovoNordisk
- LFB SA HEMA Biologics
- AryoGen Pharmed
- GENERIUM
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Prefilled Syringe
- Vial
Segment by Application
- Congenital Hemophilia
- Acquired Hemophilia
- Other
CHAPTER OUTLINE
Chapter 1: Introduces Human Coagulation Factor VII definition, global sales (volume and revenue), China market size, China percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Human Coagulation Factor VII companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Human Coagulation Factor VII in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VII sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Human Coagulation Factor VII Product Introduction
1.2 Global Human Coagulation Factor VII Outlook 2019 VS 2023 VS 2030
1.2.1 Global Human Coagulation Factor VII Sales in US$ Million for the Year 2019-2030
1.2.2 Global Human Coagulation Factor VII Sales in Volume for the Year 2019-2030
1.3 China Human Coagulation Factor VII Outlook 2019 VS 2023 VS 2030
1.3.1 China Human Coagulation Factor VII Sales in US$ Million for the Year 2019-2030
1.3.2 China Human Coagulation Factor VII Sales in Volume for the Year 2019-2030
1.4 Human Coagulation Factor VII Market Size, China VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of China Human Coagulation Factor VII in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Human Coagulation Factor VII Market Size, China VS Global, 2019 VS 2023 VS 2030
1.5 Human Coagulation Factor VII Market Dynamics
1.5.1 Human Coagulation Factor VII Industry Trends
1.5.2 Human Coagulation Factor VII Market Drivers
1.5.3 Human Coagulation Factor VII Market Challenges
1.5.4 Human Coagulation Factor VII Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Human Coagulation Factor VII by Type
2.1 Human Coagulation Factor VII Market by Type
2.1.1 Prefilled Syringe
2.1.2 Vial
2.2 Global Human Coagulation Factor VII Market Size by Type
2.2.1 Global Human Coagulation Factor VII Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Human Coagulation Factor VII Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Human Coagulation Factor VII Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 China Human Coagulation Factor VII Market Size by Type
2.3.1 China Human Coagulation Factor VII Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 China Human Coagulation Factor VII Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 China Human Coagulation Factor VII Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Human Coagulation Factor VII by Application
3.1 Human Coagulation Factor VII Market by Application
3.1.1 Congenital Hemophilia
3.1.2 Acquired Hemophilia
3.1.3 Other
3.2 Global Human Coagulation Factor VII Market Size by Application
3.2.1 Global Human Coagulation Factor VII Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Human Coagulation Factor VII Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Human Coagulation Factor VII Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 China Human Coagulation Factor VII Market Size by Application
3.3.1 China Human Coagulation Factor VII Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 China Human Coagulation Factor VII Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 China Human Coagulation Factor VII Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Human Coagulation Factor VII Competitor Landscape by Company
4.1 Global Human Coagulation Factor VII Market Size by Company
4.1.1 Global Key Manufacturers of Human Coagulation Factor VII, Ranked by Revenue (2023)
4.1.2 Global Human Coagulation Factor VII Revenue by Manufacturer (2019-2024)
4.1.3 Global Human Coagulation Factor VII Sales by Manufacturer (2019-2024)
4.1.4 Global Human Coagulation Factor VII Price by Manufacturer (2019-2024)
4.2 Global Human Coagulation Factor VII Concentration Ratio (CR)
4.2.1 Human Coagulation Factor VII Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Coagulation Factor VII in 2023
4.2.3 Global Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Human Coagulation Factor VII, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Human Coagulation Factor VII, Product Offered and Application
4.5 Global Key Manufacturers of Human Coagulation Factor VII, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 China Human Coagulation Factor VII Market Size by Company
4.7.1 Key Players of Human Coagulation Factor VII in China, Ranked by Revenue (2023)
4.7.2 China Human Coagulation Factor VII Revenue by Players (2019-2024)
4.7.3 China Human Coagulation Factor VII Sales by Players (2019-2024)
5 Global Human Coagulation Factor VII Market Size by Region
5.1 Global Human Coagulation Factor VII Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Coagulation Factor VII Market Size in Volume by Region (2019-2030)
5.2.1 Global Human Coagulation Factor VII Sales in Volume by Region: 2019-2024
5.2.2 Global Human Coagulation Factor VII Sales in Volume Forecast by Region (2025-2030)
5.3 Global Human Coagulation Factor VII Market Size in Value by Region (2019-2030)
5.3.1 Global Human Coagulation Factor VII Sales in Value by Region: 2019-2024
5.3.2 Global Human Coagulation Factor VII Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Human Coagulation Factor VII Market Size YoY Growth 2019-2030
6.2 Americas Human Coagulation Factor VII Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Human Coagulation Factor VII Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Human Coagulation Factor VII Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Human Coagulation Factor VII Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Human Coagulation Factor VII Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Human Coagulation Factor VII Market Size YoY Growth 2019-2030
7.2 EMEA Human Coagulation Factor VII Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Human Coagulation Factor VII Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Human Coagulation Factor VII Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Human Coagulation Factor VII Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Human Coagulation Factor VII Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Human Coagulation Factor VII Market Size YoY Growth 2019-2030
8.2 China Human Coagulation Factor VII Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Human Coagulation Factor VII Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Human Coagulation Factor VII Market Size YoY Growth 2019-2030
9.2 APAC Human Coagulation Factor VII Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Human Coagulation Factor VII Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Human Coagulation Factor VII Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Human Coagulation Factor VII Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Human Coagulation Factor VII Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 NovoNordisk
10.1.1 NovoNordisk Company Information
10.1.2 NovoNordisk Description and Business Overview
10.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue and Gross Margin (2019-2024)
10.1.4 NovoNordisk Human Coagulation Factor VII Products Offered
10.1.5 NovoNordisk Recent Development
10.2 LFB SA HEMA Biologics
10.2.1 LFB SA HEMA Biologics Company Information
10.2.2 LFB SA HEMA Biologics Description and Business Overview
10.2.3 LFB SA HEMA Biologics Human Coagulation Factor VII Sales, Revenue and Gross Margin (2019-2024)
10.2.4 LFB SA HEMA Biologics Human Coagulation Factor VII Products Offered
10.2.5 LFB SA HEMA Biologics Recent Development
10.3 AryoGen Pharmed
10.3.1 AryoGen Pharmed Company Information
10.3.2 AryoGen Pharmed Description and Business Overview
10.3.3 AryoGen Pharmed Human Coagulation Factor VII Sales, Revenue and Gross Margin (2019-2024)
10.3.4 AryoGen Pharmed Human Coagulation Factor VII Products Offered
10.3.5 AryoGen Pharmed Recent Development
10.4 GENERIUM
10.4.1 GENERIUM Company Information
10.4.2 GENERIUM Description and Business Overview
10.4.3 GENERIUM Human Coagulation Factor VII Sales, Revenue and Gross Margin (2019-2024)
10.4.4 GENERIUM Human Coagulation Factor VII Products Offered
10.4.5 GENERIUM Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Human Coagulation Factor VII Industry Chain Analysis
11.2 Human Coagulation Factor VII Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Human Coagulation Factor VII Production Mode & Process
11.4 Human Coagulation Factor VII Sales and Marketing
11.4.1 Human Coagulation Factor VII Sales Channels
11.4.2 Human Coagulation Factor VII Distributors
11.5 Human Coagulation Factor VII Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Human Coagulation Factor VII CAGR in Value, China VS Global, 2019 VS 2023 VS 2030
Table 2. Human Coagulation Factor VII Market Trends
Table 3. Human Coagulation Factor VII Market Drivers
Table 4. Human Coagulation Factor VII Market Challenges
Table 5. Human Coagulation Factor VII Market Restraints
Table 6. Global Human Coagulation Factor VII Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. China Human Coagulation Factor VII Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Human Coagulation Factor VII Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. China Human Coagulation Factor VII Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Key Manufacturers of Human Coagulation Factor VII, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Human Coagulation Factor VII Revenue by Manufacturer, (US$ Million) & (2019-2024)
Table 12. Global Human Coagulation Factor VII Revenue Share by Manufacturer, 2019-2024
Table 13. Global Human Coagulation Factor VII Sales by Manufacturer, (K Units), 2019-2024
Table 14. Global Human Coagulation Factor VII Sales Share by Manufacturer, 2019-2024
Table 15. Global Human Coagulation Factor VII Price by Manufacturer (2019-2024) & (US$/Unit)
Table 16. Global Human Coagulation Factor VII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Human Coagulation Factor VII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VII as of 2023)
Table 18. Global Key Manufacturers of Human Coagulation Factor VII, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Human Coagulation Factor VII, Product Offered and Application
Table 20. Global Key Manufacturers of Human Coagulation Factor VII, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Human Coagulation Factor VII in China, Ranked by Revenue (2023) & (US$ million)
Table 23. China Human Coagulation Factor VII Revenue by Players, (US$ Million) & (2019-2024)
Table 24. China Human Coagulation Factor VII Revenue Share by Players, (2019-2024)
Table 25. China Human Coagulation Factor VII Sales by Players, (K Units) & (2019-2024)
Table 26. China Human Coagulation Factor VII Sales Share by Players, (2019-2024)
Table 27. Global Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 28. Global Human Coagulation Factor VII Sales in Volume by Region (2019-2024) & (K Units)
Table 29. Global Human Coagulation Factor VII Sales in Volume Forecast by Region (2025-2030) & (K Units)
Table 30. Global Human Coagulation Factor VII Sales in Value by Region (2019-2024) & (US$ Million)
Table 31. Global Human Coagulation Factor VII Sales in Value Forecast by Region (2025-2030) & (US$ Million)
Table 32. Americas Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. Americas Human Coagulation Factor VII Sales in Value by Country (2019-2024) & (US$ Million)
Table 34. Americas Human Coagulation Factor VII Sales in Value by Country (2025-2030) & (US$ Million)
Table 35. Americas Human Coagulation Factor VII Sales in Volume by Country (2019-2024) & (K Units)
Table 36. Americas Human Coagulation Factor VII Sales in Volume by Country (2025-2030) & (K Units)
Table 37. EMEA Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. EMEA Human Coagulation Factor VII Sales in Value by Country (2019-2024) & (US$ Million)
Table 39. EMEA Human Coagulation Factor VII Sales in Value by Country (2025-2030) & (US$ Million)
Table 40. EMEA Human Coagulation Factor VII Sales in Volume by Country (2019-2024) & (K Units)
Table 41. EMEA Human Coagulation Factor VII Sales in Volume by Country (2025-2030) & (K Units)
Table 42. APAC Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. APAC Human Coagulation Factor VII Sales in Value by Country (2019-2024) & (US$ Million)
Table 44. APAC Human Coagulation Factor VII Sales in Value by Country (2025-2030) & (US$ Million)
Table 45. APAC Human Coagulation Factor VII Sales in Volume by Country (2019-2024) & (K Units)
Table 46. APAC Human Coagulation Factor VII Sales in Volume by Country (2025-2030) & (K Units)
Table 47. NovoNordisk Company Information
Table 48. NovoNordisk Description and Business Overview
Table 49. NovoNordisk Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 50. NovoNordisk Human Coagulation Factor VII Product
Table 51. NovoNordisk Recent Development
Table 52. LFB SA HEMA Biologics Company Information
Table 53. LFB SA HEMA Biologics Description and Business Overview
Table 54. LFB SA HEMA Biologics Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 55. LFB SA HEMA Biologics Human Coagulation Factor VII Product
Table 56. LFB SA HEMA Biologics Recent Development
Table 57. AryoGen Pharmed Company Information
Table 58. AryoGen Pharmed Description and Business Overview
Table 59. AryoGen Pharmed Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AryoGen Pharmed Human Coagulation Factor VII Product
Table 61. AryoGen Pharmed Recent Development
Table 62. GENERIUM Company Information
Table 63. GENERIUM Description and Business Overview
Table 64. GENERIUM Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. GENERIUM Human Coagulation Factor VII Product
Table 66. GENERIUM Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Human Coagulation Factor VII Distributors List
Table 70. Human Coagulation Factor VII Customers List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VII Product Picture
Figure 2. Global Human Coagulation Factor VII Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Coagulation Factor VII Market Size 2019-2030 (US$ Million)
Figure 4. Global Human Coagulation Factor VII Sales 2019-2030 (K Units)
Figure 5. China Human Coagulation Factor VII Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 6. China Human Coagulation Factor VII Market Size 2019-2030 (US$ Million)
Figure 7. China Human Coagulation Factor VII Sales 2019-2030 (K Units)
Figure 8. China Human Coagulation Factor VII Market Share in Global, in Value (US$ Million) 2019-2030
Figure 9. China Human Coagulation Factor VII Market Share in Global, in Volume (K Units) 2019-2030
Figure 10. Human Coagulation Factor VII Report Years Considered
Figure 11. Product Picture of Prefilled Syringe
Figure 12. Product Picture of Vial
Figure 13. Global Human Coagulation Factor VII Market Share by Type in 2023 & 2030
Figure 14. Global Human Coagulation Factor VII Sales in Value by Type (2019-2030) & (US$ Million)
Figure 15. Global Human Coagulation Factor VII Sales Market Share in Value by Type (2019-2030)
Figure 16. Global Human Coagulation Factor VII Sales by Type (2019-2030) & (K Units)
Figure 17. Global Human Coagulation Factor VII Sales Market Share in Volume by Type (2019-2030)
Figure 18. Global Human Coagulation Factor VII Price by Type (2019-2030) & (US$/Unit)
Figure 19. China Human Coagulation Factor VII Market Share by Type in 2023 & 2030
Figure 20. China Human Coagulation Factor VII Sales in Value by Type (2019-2030) & (US$ Million)
Figure 21. China Human Coagulation Factor VII Sales Market Share in Value by Type (2019-2030)
Figure 22. China Human Coagulation Factor VII Sales by Type (2019-2030) & (K Units)
Figure 23. China Human Coagulation Factor VII Sales Market Share in Volume by Type (2019-2030)
Figure 24. China Human Coagulation Factor VII Price by Type (2019-2030) & (US$/Unit)
Figure 25. Product Picture of Congenital Hemophilia
Figure 26. Product Picture of Acquired Hemophilia
Figure 27. Product Picture of Other
Figure 28. Global Human Coagulation Factor VII Market Share by Application in 2023 & 2030
Figure 29. Global Human Coagulation Factor VII Sales in Value by Application (2019-2030) & (US$ Million)
Figure 30. Global Human Coagulation Factor VII Sales Market Share in Value by Application (2019-2030)
Figure 31. Global Human Coagulation Factor VII Sales by Application (2019-2030) & (K Units)
Figure 32. Global Human Coagulation Factor VII Sales Market Share in Volume by Application (2019-2030)
Figure 33. Global Human Coagulation Factor VII Price by Application (2019-2030) & (US$/Unit)
Figure 34. China Human Coagulation Factor VII Market Share by Application in 2023 & 2030
Figure 35. China Human Coagulation Factor VII Sales in Value by Application (2019-2030) & (US$ Million)
Figure 36. China Human Coagulation Factor VII Sales Market Share in Value by Application (2019-2030)
Figure 37. China Human Coagulation Factor VII Sales by Application (2019-2030) & (K Units)
Figure 38. China Human Coagulation Factor VII Sales Market Share in Volume by Application (2019-2030)
Figure 39. China Human Coagulation Factor VII Price by Application (2019-2030) & (US$/Unit)
Figure 40. The Top 5 and 10 Largest Manufacturers of Human Coagulation Factor VII in the World: Market Share by Human Coagulation Factor VII Revenue in 2023
Figure 41. Global Human Coagulation Factor VII Market Size Market Share by Region: 2019 VS 2023 VS 2030
Figure 42. Global Human Coagulation Factor VII Sales in Volume Market Share by Region (2019-2030)
Figure 43. Global Human Coagulation Factor VII Sales in Value Market Share by Region (2019-2030)
Figure 44. Americas Human Coagulation Factor VII Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 45. Americas Human Coagulation Factor VII Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 46. Americas Human Coagulation Factor VII Sales by Type (2019-2030) & (K Units)
Figure 47. Americas Human Coagulation Factor VII Sales Market Share in Volume by Type (2019-2030)
Figure 48. Americas Human Coagulation Factor VII Sales by Application (2019-2030) & (K Units)
Figure 49. Americas Human Coagulation Factor VII Sales Market Share in Volume by Application (2019-2030)
Figure 50. United States Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. Canada Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Mexico Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. EMEA Human Coagulation Factor VII Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 55. EMEA Human Coagulation Factor VII Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 56. EMEA Human Coagulation Factor VII Sales by Type (2019-2030) & (K Units)
Figure 57. EMEA Human Coagulation Factor VII Sales Market Share in Volume by Type (2019-2030)
Figure 58. EMEA Human Coagulation Factor VII Sales by Application (2019-2030) & (K Units)
Figure 59. EMEA Human Coagulation Factor VII Sales Market Share in Volume by Application (2019-2030)
Figure 60. Europe Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Middle East Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Africa Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 63. China Human Coagulation Factor VII Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 64. China Human Coagulation Factor VII Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 65. China Human Coagulation Factor VII Sales by Type (2019-2030) & (K Units)
Figure 66. China Human Coagulation Factor VII Sales Market Share in Volume by Type (2019-2030)
Figure 67. China Human Coagulation Factor VII Sales by Application (2019-2030) & (K Units)
Figure 68. China Human Coagulation Factor VII Sales Market Share in Volume by Application (2019-2030)
Figure 69. APAC Human Coagulation Factor VII Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 70. APAC Human Coagulation Factor VII Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 71. APAC Human Coagulation Factor VII Sales by Type (2019-2030) & (K Units)
Figure 72. APAC Human Coagulation Factor VII Sales Market Share in Volume by Type (2019-2030)
Figure 73. APAC Human Coagulation Factor VII Sales by Application (2019-2030) & (K Units)
Figure 74. APAC Human Coagulation Factor VII Sales Market Share in Volume by Application (2019-2030)
Figure 75. Japan Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. South Korea Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. China Taiwan Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 78. Southeast Asia Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. India Human Coagulation Factor VII Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Human Coagulation Factor VII Value Chain
Figure 81. Human Coagulation Factor VII Production Process
Figure 82. Channels of Distribution (Direct Vs Distribution)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Human Coagulation Factor VII market?
The top companies in the global Human Coagulation Factor VII market are NovoNordisk、LFB SA HEMA Biologics、AryoGen Pharmed.
What was the global market size of Human Coagulation Factor VII in 2024?
Which region is expected to have the highest market share?
What was the global market size of Human Coagulation Factor VII in 2030?
What is the annual compound growth rate of the global Human Coagulation Factor VII market size from 2024 to 2030?
Related Reports
Global Human Coagulation Factor VII Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Coagulation Factor VII market size was US$ 1293 million in 2025 and is forecast to reach a readjusted size of US$ 1661 million by 2032 with a CAGR of 3.7% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 66
USD 4250.00
(Single User License)
Global Human Coagulation Factor VII Market Research Report 2026
The global Human Coagulation Factor VII market was valued at US$ 1293 million in 2025 and is anticipated to reach US$ 1661 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 91
USD 2900.00
(Single User License)
Human Coagulation Factor VII- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Coagulation Factor VII was estimated to be worth US$ 1293 million in 2025 and is projected to reach US$ 1661 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 89
USD 3950.00
(Single User License)
Global Human Coagulation Factor VII Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Coagulation Factor VII market is projected to grow from US$ 1251 million in 2024 to US$ 1608 million by 2031, at a CAGR of 3.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 117
USD 4900.00
(Single User License)
Global Human Coagulation Factor VII Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Coagulation Factor VII was estimated to be worth US$ 1251 million and is forecast to reach approximately US$ 1608 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 106
USD 5900.00
(Single User License)
Global Human Coagulation Factor VII Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Coagulation Factor VII market size was US$ 1251 million in 2024 and is forecast to a readjusted size of US$ 1608 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 71
USD 4250.00
(Single User License)
Human Coagulation Factor VII- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Coagulation Factor VII was estimated to be worth US$ 1251 million in 2024 and is forecast to a readjusted size of US$ 1608 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 88
USD 3950.00
(Single User License)
Global Human Coagulation Factor VII Market Research Report 2025
The global market for Human Coagulation Factor VII was valued at US$ 1251 million in the year 2024 and is projected to reach a revised size of US$ 1608 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published Date: 2025-01-16
Pages: 68
USD 2900.00
(Single User License)
Human Coagulation Factor VII- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
Published Date: 2024-10-17
Pages: 82
USD 3950.00
(Single User License)
Global Human Coagulation Factor VII Market Insights, Forecast to 2030
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
Published Date: 2024-10-17
Pages: 106
USD 4900.00
(Single User License)
Global Human Coagulation Factor VII Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Coagulation Factor VII market size was US$ 1293 million in 2025 and is forecast to reach a readjusted size of US$ 1661 million by 2032 with a CAGR of 3.7% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 66
USD 4250.00 (Single User License)Global Human Coagulation Factor VII Market Research Report 2026
The global Human Coagulation Factor VII market was valued at US$ 1293 million in 2025 and is anticipated to reach US$ 1661 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 91
USD 2900.00 (Single User License)Human Coagulation Factor VII- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Coagulation Factor VII was estimated to be worth US$ 1293 million in 2025 and is projected to reach US$ 1661 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 89
USD 3950.00 (Single User License)Global Human Coagulation Factor VII Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Coagulation Factor VII market is projected to grow from US$ 1251 million in 2024 to US$ 1608 million by 2031, at a CAGR of 3.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 117
USD 4900.00 (Single User License)Global Human Coagulation Factor VII Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Coagulation Factor VII was estimated to be worth US$ 1251 million and is forecast to reach approximately US$ 1608 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 106
USD 5900.00 (Single User License)Global Human Coagulation Factor VII Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Coagulation Factor VII market size was US$ 1251 million in 2024 and is forecast to a readjusted size of US$ 1608 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 71
USD 4250.00 (Single User License)Human Coagulation Factor VII- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Coagulation Factor VII was estimated to be worth US$ 1251 million in 2024 and is forecast to a readjusted size of US$ 1608 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 88
USD 3950.00 (Single User License)Global Human Coagulation Factor VII Market Research Report 2025
The global market for Human Coagulation Factor VII was valued at US$ 1251 million in the year 2024 and is projected to reach a revised size of US$ 1608 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published: 2025-01-16
Pages: 68
USD 2900.00 (Single User License)Human Coagulation Factor VII- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
Published: 2024-10-17
Pages: 82
USD 3950.00 (Single User License)Global Human Coagulation Factor VII Market Insights, Forecast to 2030
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
Published: 2024-10-17
Pages: 106
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now